Sunnymeath Asset Management’s Pfizer PFE Stock Holding History

Sunnymeath Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.35M	Buy	43,918 +3,283	+8%	+$100K	1.9%	17
2016 Q3	$960K	Sell	40,635 -5,955	-13%	-$199K	2.1%	13
2016 Q2	$1.57M	Sell	46,590 -632	-1%	-$20.2K	2.29%	6
2016 Q1	$1.34M	Sell	47,222 -8,000	-14%	-$229K	2.04%	13
2015 Q4	$1.69M	Buy	+55,222	New	+$1.74M	2.69%	6

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sunnymeath Asset Management's PFE Position: Q4 2016 in Review

Sunnymeath Asset Management increased its Pfizer (PFE) stake by 8.1% in Q4 2016, buying an estimated $100K and bringing the position to 43,918 shares worth $1.35M. The position accounts for 1.9% of the portfolio, ranked #17.

Sunnymeath Asset Management first reported a position in PFE in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.69M in Q4 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Sunnymeath Asset Management held 43,918 shares of Pfizer worth $1.35M as of Q4 2016.
Sunnymeath Asset Management bought 3,283 Pfizer shares in Q4 2016, an estimated $100K.
Pfizer made up 1.9% of Sunnymeath Asset Management's portfolio in Q4 2016, its #17 holding.
Sunnymeath Asset Management first reported a position in Pfizer in Q4 2015 and has held it in 5 quarters since.
Sunnymeath Asset Management's Pfizer position peaked at $1.69M in Q4 2015.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.